Journal
/
Immunology and Infection
/
Uno screening multiplexed ad alto rendimento per diabete di tipo 1, celiachia e COVID-19
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Please note that all translations are automatically generated. Click here for the English version.

Uno screening multiplexed ad alto rendimento per diabete di tipo 1, celiachia e COVID-19

italiano

Automatically Generated

2,388 Views

•

06:46 min

•

July 05, 2022

DOI:

10.3791/63787-v

DOI:
10.3791/63787-v

•

06:46 min
July 05, 2022

•

5 Views
, , , , ,
1Barbara Davis Center for Diabetes,University of Colorado School of Medicine, 2Department of Endocrinology, Guangzhou First People’s Hospital, School of Medicine,South China University of Technology

Summary

Automatically generated

In linea con l'urgente necessità di screening per il diabete di tipo 1, la celiachia e la malattia da coronavirus 2019, abbiamo sviluppato un test di elettrochemiluminescenza 6-Plex ad alta produttività per rilevare simultaneamente tutti e quattro gli autoanticorpi delle isole, gli autoanticorpi della transglutaminasi tissutale e gli anticorpi contro il dominio di legame del recettore della sindrome respiratoria acuta grave coronavirus 2.

Explore More Videos

Multiplex AssayAutoantibody ScreeningType 1 DiabetesCeliac DiseaseCOVID-19GAD65SARS-CoV-2 RBDIA-2TTGZnT8ProinsulinBiotinylated AntigenRuthenium-labeled AntigenHigh-throughput ScreeningEarly Disease PredictionPrecise Diagnosis

Read Article

Cite this Article

Jia, X., He, L., Miao, D., Zhang, C., Rewers, M., Yu, L. A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19. J. Vis. Exp. (185), e63787, doi:10.3791/63787 (2022).

Download .ris file

Copy

Share Video

.

Copy